NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
- Diluted EPS, 2025
- $4.67
- YoY, 2025
- +41.9%
- 5-year CAGR
- +2.3%
Diluted EPS
Diluted EPS by fiscal year
| Period | EPS | YoY |
|---|---|---|
| 2025 | $4.67 | +41.9% |
| 2024 | $3.29 | +33.2% |
| 2023 | $2.47 | +58.3% |
| 2022 | $1.56 | +69.6% |
| 2021 | $0.92 | −77.9% |
| 2020 | $4.16 | +966.7% |
| 2019 | $0.39 | +77.3% |
| 2018 | $0.22 | — |
| 2017 | −$1.62 | — |
| 2016 | −$1.63 | — |
| 2015 | −$1.05 | — |
| 2014 | −$0.81 | — |
| 2013 | −$0.69 | — |
| 2012 | $0.08 | −88.1% |
| 2011 | $0.67 | — |
| 2010 | −$0.15 | — |
| 2009 | −$1.30 | — |